How to Tell If Your MGD Treatment Is Working

Key overview

  • Symptoms improve before signs. Comfort can shift in two to four weeks while the glands still look unchanged to an examiner for months.
  • Measure something weekly. An impression of how your eyes have been drifts; a score does not.
  • The most useful early markers are morning grittiness, how long you last on a screen, and how many times a day you reach for drops.
  • Six weeks of genuinely consistent treatment with no change in any of those is a reason to change the plan, not to try harder.

Meibomian gland dysfunction improves slowly and unevenly, which makes it unusually easy to abandon treatment that is working and unusually easy to persist with treatment that is not. The distinction is worth being deliberate about.

What improves first

Symptoms lead signs, generally by months. The order is roughly: how the eyes feel on waking, then how long they stay comfortable through the day, then the amount of lubricant you need, then measurable tear film stability, and last of all the appearance and structure of the glands themselves.

This matters because the things a clinician measures — break-up time, staining, osmolarity — and the things meibography shows are the slowest items on that list. A three-month scan that looks identical to the first one is not evidence that nothing happened. Equally, gland tissue that has already been lost does not return, as whether glands grow back sets out, so structure is the wrong thing to be watching for reassurance.

What to measure

Pick three, record them weekly, and always on the same day and at the same time of day.

  • Morning grittiness, 0 to 10. Scored within a few minutes of waking. This is often the first thing to shift, because overnight is when an unstable tear film does its worst.
  • Comfortable screen time. How long before your eyes actively complain. Blunt, but it tracks real function.
  • Drops per day. A count, not an impression. It is the most objective number available to you at home.

A formal symptom questionnaire is better than any of these if you will actually complete it. The OSDI is the standard one, it takes a couple of minutes, and repeating it monthly gives you a number that is comparable over time and that an optometrist will recognise.

Realistic checkpoints

Point What is reasonable to expect
Week 1 Nothing, or a mild transient worsening as the lid margin is handled for the first time
Weeks 2-4 First change in morning symptoms; expression yields a little more freely
Weeks 6-8 Fewer drops, longer comfortable stretches, fewer bad days rather than no bad days
3 months Clinically measurable change in tear film stability in many people; gland structure unchanged
6 months+ The realistic horizon for a settled baseline, maintained rather than cured

Fluctuation within all of that is normal. MGD has good weeks and bad weeks regardless of treatment, and a bad week does not mean the routine has failed. Trends over a month are the signal; single days are noise.

What counts as no response

Six weeks of treatment you have genuinely done — most days, full duration, correct order — with no movement in any of your three measures is a meaningful negative result. So is deterioration at any point, and so is any new pain, lid swelling, lash loss or change in vision, which should be looked at promptly rather than monitored.

What to change, in order

Before concluding that home treatment does not work, confirm that it was home treatment. In practice the failure is usually in the heat: too cool, too short, or a source that cools within the first two minutes. Six reasons warm compresses fail is the list to work through first.

After that, the productive question is whether the diagnosis is complete. An inflamed lid margin, mites, rosacea, an aqueous-deficient component or lids that do not fully close at night all sit behind treatment that plateaus, and each is treated differently. That is a consultation, not a purchase.

Part of our guide to Meibomian Gland Dysfunction & Heat Therapy.